DRL has paid Eton Pharma, located in the United States, $50 million to purchase their injectable portfolio.

On Friday, Dr. Reddy’s made the announcement that it had completed the purchase of a portfolio of branded and generic injectable pharmaceuticals from Eton Pharmaceuticals, which is situated in Deer Park, Illinois. In accordance with the terms of the agreement, Dr. Reddy’s will make an initial cash payment of $5 million, in addition to potential … Read more

A variant-specific Covid-19 vaccine developed by Sanofi and GSK was proven to be effective against Omicron.

According to statements made by both Sanofi and GSK on Friday, late-stage research on an experimental COVID-19 vaccine demonstrated that the shot protects against the Omicron version of the virus. This information was revealed by the two pharmaceutical firms. The so-called bivalent vaccination is designed to protect against both the original Wuhan strain of the … Read more

Dr. Reddy’s Laboratories is making plans to expand its business through mergers and acquisitions.

Dr. Reddy’s Laboratories has stated that one of its goals is to be among the top five pharmaceutical companies in India. This objective will be accomplished primarily through mergers and acquisitions (M&A) of chronically relevant brands, companies, and in-licensing deals, as well as through the expansion of its nutraceutical and over-the-counter (OTC) product lines. The … Read more